Boards and Committees - Health Bureau (2025)

Chinese Medicine Development Committee

A. Terms of Reference

1. To examine the current landscape and the needs of the Chinese medicine sector in the areas of personnel training and professional development, Chinese medical services, scientific research and development of the Chinese medicines industry, etc;
2. To explore the future development directions and goals of the above areas;
3. To set priorities for the development goals of the above areas;
4. To recommend feasible strategies and measures for projects for priority development; and
5. To monitor the implementation of relevant measures.

B. Membership (1 February 2025 to 31 January 2027)

Two standing Subcommittees have been formed under the Chinese Medicine Development Committee, namely the Chinese Medicine Practice Subcommittee and Chinese Medicines Industry Subcommittee. The Chinese Medicine Development Blueprint Subcommittee has also been established under the Chinese Medicine Development Committee to gauge a wider spectrum of views in formulating the Chinese Medicine Development Blueprint.

Chinese Medicine Practice Subcommittee

C. Terms of Reference

1. To study the needs for the professional development of Chinese medicine practitioners and explore means for the development of Chinese medicine practice specialties, in collaboration with the Chinese Medicine Practitioners Board of the Chinese Medicine Council of Hong Kong and the Steering Committee on Strategic Review on Healthcare Manpower Planning and Professional Development;
2. To explore means to facilitate the collaboration of Chinese medicine practitioners and medical doctors in the provision of clinical services to patients;
3. To explore means to expand the role of Chinese medicine in the public healthcare system; and
4. To advise on the development of Chinese Medicine Hospital.

D. Membership (1 February 2025 to 31 January 2027)

Chinese Medicines Industry Subcommittee

E. Terms of Reference

1. To explore means to enhance the quality of Chinese medicines in Hong Kong, including ways to facilitate the implementation of the requirements of Good Manufacturing Practice and Good Clinical Practice, in collaboration with the Chinese Medicines Board of the Chinese Medicine Council of Hong Kong;
2. To set the priority areas of and facilitate research on Chinese medicines, in collaboration with the Committee on Research and Development of Chinese Medicines;
3. To explore means to promote Hong Kong as a centre for testing and certification of Chinese medicines; and
4. To promote the status of and explore business opportunities for the Chinese medicines industry in Hong Kong.

F. Membership (1 February 2025 to 31 January 2027)

Chinese Medicine Development Blueprint Subcommittee

G. Terms of Reference

The Subcommittee will oversee and co-ordinate the formulation of the blueprint for the long-term development of Chinese medicine in Hong Kong in collaboration with stakeholders in the Chinese medicine sector, including:

1. To map out the vision, positioning, directions and overall strategy for the development of Chinese medicine;
2. To consider and discuss the views and plans tendered by its working groups on the Chinese medicine service development, industry development, professional development, research and talent nurturing, technology application, and cultural popularisation; and
3. To map out strategies, set the short, medium and long-term objectives and make recommendations on the above matters.

H. Membership (1 September 2024 to 31 August 2026)

I. Enquiry